Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04438187 · ClinicalTrials.gov registry record · NA
Trial of Antimicrobial Restraint in Presumed Pneumonia
A NA study of Sepsis and Healthcare-Associated Pneumonia, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 1
- Study location
NCT04438187 is a NA study of Sepsis and Healthcare-Associated Pneumonia that has completed, run by University of Kansas Medical Center. The registered enrollment target is 186 participants, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04438187, a NA study of Sepsis and Healthcare-Associated Pneumonia, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this cluster-randomized crossover study is to determine the effect of delaying antimicrobial initiation until objective microbiologic data is obtained in patients with presumed ICU-acquired pneumonia without septic shock.
Conditions Studied
Interventions
- OTHER antimicrobial initiation
Study Locations (1)
Kansas
- KU Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04438187
The ClinicalTrials.gov registry entry for NCT04438187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (97% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which antimicrobial initiation is the first listed.
NCT04438187 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT04438187 about?
NCT04438187 is a clinical study titled "Trial of Antimicrobial Restraint in Presumed Pneumonia". The objective of this cluster-randomized crossover study is to determine the effect of delaying antimicrobial initiation until objective microbiologic data is obtained in patients with presumed ICU-acquired pneumonia without septic shock.
What is the current status of trial NCT04438187?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2021-02-01. Estimated completion is 2022-06-30.
What conditions does trial NCT04438187 study?
This clinical trial studies the following conditions: Sepsis, Healthcare-Associated Pneumonia.
What interventions are being tested in trial NCT04438187?
The interventions under investigation include: antimicrobial initiation (OTHER).
Who is sponsoring clinical trial NCT04438187?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04438187 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.